To test the hypothesis that blocking the translocation of long Fas into mitochondria via CPT1 could enhance glucose utilization and ameliorate Huntington’s symptoms [10,26,30,47], we treated HD flies with Teglicar [24]. This evidence concerns the gene CPT1A and Huntington disease.